Ching YP - Search Results

1

The role of p21-activated kinases in hepatocellular carcinoma metastasis.

Tse EY, Ching YP. Tse EY, et al. Among authors: ching yp. J Mol Signal. 2014 Aug 1;9:7. doi: 10.1186/1750-2187-9-7. eCollection 2014. J Mol Signal. 2014. PMID: 25093037 Free PMC article. Review.

2

Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.

Mak GW, Chan MM, Leong VY, Lee JM, Yau TO, Ng IO, Ching YP. Mak GW, et al. Among authors: ching yp. Cancer Res. 2011 Apr 15;71(8):2949-58. doi: 10.1158/0008-5472.CAN-10-4046. Epub 2011 Mar 8. Cancer Res. 2011. PMID: 21385901 Free article.

3

AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells.

Lee CW, Wong LL, Tse EY, Liu HF, Leong VY, Lee JM, Hardie DG, Ng IO, Ching YP. Lee CW, et al. Among authors: ching yp. Cancer Res. 2012 Sep 1;72(17):4394-404. doi: 10.1158/0008-5472.CAN-12-0429. Epub 2012 Jun 22. Cancer Res. 2012. PMID: 22728651 Free PMC article.

4

Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.

Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, Ng IO. Ching YP, et al. J Biol Chem. 2003 Mar 21;278(12):10824-30. doi: 10.1074/jbc.M208310200. Epub 2003 Jan 16. J Biol Chem. 2003. PMID: 12531887 Free article.

5

Identification of an autoinhibitory domain of p21-activated protein kinase 5.

Ching YP, Leong VY, Wong CM, Kung HF. Ching YP, et al. J Biol Chem. 2003 Sep 5;278(36):33621-4. doi: 10.1074/jbc.C300234200. Epub 2003 Jul 14. J Biol Chem. 2003. PMID: 12860998 Free article.

6

P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.

Ching YP, Leong VY, Lee MF, Xu HT, Jin DY, Ng IO. Ching YP, et al. Cancer Res. 2007 Apr 15;67(8):3601-8. doi: 10.1158/0008-5472.CAN-06-3994. Cancer Res. 2007. PMID: 17440071

7

Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells.

Tsang CM, Lau EP, Di K, Cheung PY, Hau PM, Ching YP, Wong YC, Cheung AL, Wan TS, Tong Y, Tsao SW, Feng Y. Tsang CM, et al. Among authors: ching yp. Int J Mol Med. 2009 Jul;24(1):131-8. doi: 10.3892/ijmm_00000216. Int J Mol Med. 2009. PMID: 19513545

8

Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma.

Hui IC, Tung EK, Sze KM, Ching YP, Ng IO. Hui IC, et al. Among authors: ching yp. Liver Int. 2010 Jan;30(1):65-75. doi: 10.1111/j.1478-3231.2009.02117.x. Epub 2009 Oct 20. Liver Int. 2010. PMID: 19845851 Free article.

9

The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2.

Lai WL, Hung WY, Wong LL, Zhou Y, Leong VY, Lee JM, Ng IO, Jin DY, Ching YP. Lai WL, et al. Among authors: ching yp. Hepatology. 2012 Nov;56(5):1770-81. doi: 10.1002/hep.25851. Epub 2012 Sep 17. Hepatology. 2012. PMID: 22610972

10

CDK5RAP3 is a novel repressor of p14ARF in hepatocellular carcinoma cells.

Mak GW, Lai WL, Zhou Y, Li M, Ng IO, Ching YP. Mak GW, et al. Among authors: ching yp. PLoS One. 2012;7(7):e42210. doi: 10.1371/journal.pone.0042210. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22860085 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters